Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
NCT06829706

The Efficacy of Modified Olfactory Training Method for Patients With Post-viral Olfactory Dysfunction

Led by Peking University Third Hospital · Updated on 2025-02-17

150

Participants Needed

1

Research Sites

113 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to validate the effectiveness of the modified olfactory training device, the main questions it aims to answer are: Is the modified olfactory training device effective in treating patients with post-viral olfactory dysfunction? Compared to the conventional device, how efficient is the modified olfactory training device for improving olfactory function?

CONDITIONS

Official Title

The Efficacy of Modified Olfactory Training Method for Patients With Post-viral Olfactory Dysfunction

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18-80 years old, any gender
  • Diagnosed with olfactory dysfunction after upper respiratory tract infection, confirmed by Sniffin' Sticks test including TDI value
  • Voluntarily signed informed consent form
Not Eligible

You will not qualify if you...

  • Olfactory dysfunction caused by trauma, rhinosinusitis, or other reasons
  • Presence of sinonasal disease
  • Chronic diseases such as hypertension, diabetes, bronchopneumonia, or chronic obstructive pulmonary disease
  • Serious coexisting diseases like malignant tumors with life expectancy less than 2 years
  • Inability to tolerate olfactory testing or treatment
  • Use of oral glucocorticoids, antibacterial drugs, anti-leukotrienes, antihistamines, or olfactory training within 4 weeks
  • Receiving treatments affecting olfactory recovery
  • Smoking habits
  • Currently pregnant or planning pregnancy
  • Inability to complete or comply with study requirements due to memory, behavior, depression, heavy drinking, or previous breach of contract
  • Did not consent to participate in the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Bejing

Beijing, China, 100191

Actively Recruiting

Loading map...

Research Team

D

Dawei Wu, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here